In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a anti-Pellagra vitamin Drug Master File in Korea (anti-Pellagra vitamin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of anti-Pellagra vitamin. The MFDS reviews the anti-Pellagra vitamin KDMF as part of the drug registration process and uses the information provided in the anti-Pellagra vitamin KDMF to evaluate the safety and efficacy of the drug.
After submitting a anti-Pellagra vitamin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their anti-Pellagra vitamin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of anti-Pellagra vitamin suppliers with KDMF on PharmaCompass.